Cambridge scientists create synthetic cells unlike anything in nature
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Researchers split from Musk-funded outfit aiming to stop superintelligent computers from running amok
Hit by a multibillion-euro lawsuit and rare side-effects, the jab that was going to save the world has an uncertain outlook
UK government figures suggest single shot less effective against fast-spreading Covid-19 strain
A quieter life has allowed the popular science writer more time to puzzle over black holes — and enjoy his new Canadian home
Breakthrough development will assist users in self-diagnosing issues ranging from acne to melanoma
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Very few jabs made in America have gone overseas even though there are no formal controls
Moscow’s departure brings two decades of rare co-operation with West to a close